Nagoya Medical Center

Nagoya, Aichi-ken 460-0001

0 studies enrolling now · 5 studies all time

What they study most

B-cell Lymphoma, Chronic Lymphocytic Leukemia, Intracerebral Hemorrhage, Lymphoma, Mantle-Cell, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Rheumatoid Arthritis, Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia

Studies at this site

• Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL) — Running, not enrolling
• Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL — Completed
• An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis — Completed
• Antihypertensive Treatment of Acute Cerebral Hemorrhage-II — Stopped early